Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 13, 2023
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
Whitney Ijem Initiated (VERV) at Strong Buy and Held Target at $29 on, Apr 13th, 2023
Whitney Ijem of Canaccord Genuity, Initiated "Verve Therapeutics, Inc." (VERV) at Strong Buy and Held Target at $29 on, Apr 13th, 2023.
Whitney has made no other calls on VERV in the last 4 months.
There are 2 other peers that have a rating on VERV. Out of the 2 peers that are also analyzing VERV, 1 agrees with Whitney's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Rick Bienkowski of "Cantor Fitzgerald" Initiated at Hold and Held Target at $21 on, Wednesday, February 1st, 2023
This is the rating of the analyst that currently disagrees with Whitney
- Andrea Tan of "Goldman Sachs" Initiated at Strong Sell and Held Target at $13 on, Thursday, December 15th, 2022
